Christopher M. Starr, a director at Monopar Therapeutics ($MNPR), sold shares on the open market once in the last year, totaling about $672 thousand. His most recent sale occurred on July 14, 2025. These sales rank 5,840th among 11,678 individual insiders in our database, where the average is $8.6 million across 6.4 transactions per insider. Starr made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | A | Stock Options | 2924 | $0.00 | 2,924.0000 | 6,662,930 | 9999.99% | 0.04% |
| July 14, 2025 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | S | Common Stock | 16800 | $40.00 | 15,053.0000 | 6,102,560 | 52.74% | 0.28% |
| July 14, 2025 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | X | Stock Options | 16800 | $0.00 | 0.0000 | 6,102,560 | 100.00% | 0.28% |
| July 14, 2025 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | X | Common Stock | 16800 | $0.01 | 31,853.0000 | 6,102,560 | 111.61% | 0.28% |
| March 4, 2025 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | A | Stock Options | 11365 | $0.00 | 11,365.0000 | 6,102,560 | 9999.99% | 0.19% |
| Dec. 31, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Restricted Stock Units | 2533 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Common Stock | 2533 | $0.00 | 75,263.0000 | 0 | 3.48% | 0.00% |
| Sept. 30, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Restricted Stock Units | 2533 | $0.00 | 2,533.0000 | 0 | 50.00% | 0.00% |
| Sept. 30, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Common Stock | 2533 | $0.00 | 72,730.0000 | 0 | 3.61% | 0.00% |
| June 30, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Restricted Stock Units | 2534 | $0.00 | 5,066.0000 | 0 | 33.34% | 0.00% |
| June 30, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Common Stock | 2534 | $0.00 | 70,197.0000 | 0 | 3.75% | 0.00% |
| March 31, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Restricted Stock Units | 2533 | $0.00 | 7,600.0000 | 0 | 25.00% | 0.00% |
| March 31, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Common Stock | 2533 | $0.00 | 67,663.0000 | 0 | 3.89% | 0.00% |
| Feb. 1, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | A | Stock Options | 13930 | $0.00 | 13,930.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | A | Restricted Stock Units | 10133 | $0.00 | 10,133.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2022 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Common Stock | 2859 | $0.00 | 65,130.0000 | 0 | 4.59% | 0.00% |
| Dec. 31, 2022 | Monopar Therapeutics | $MNPR | STARR CHRISTOPHER M | Director | M | Restricted Stock Units | 2859 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |